Concepedia

David B. Kanne

DB

23

Publications

4.1K

Citations

20

H-Index

1977

Active since

Affiliations

University of California, Berkeley(Current)

Aduro BioTech (United States)

Lawrence Berkeley National Laboratory

490 BioTech (United States)

Sidney Kimmel Comprehensive Cancer Center

David B. Kanne is an author at University of California, Berkeley specializing in biochemistry, medicine, and natural sciences.

Top concepts

Publications per year

1977–2018

23

Publications

23

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter et al. · Cell Reports · 2015 · 1.4K citations · Full text

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 681 citations

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 417 citations · Full text

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

Jason R. Baird, David J. Friedman, Benjamin Cottam et al. · Cancer Research · 2015 · 232 citations

, , +24

The psoralen-DNA photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5',8-trimethylpsoralen

David B. Kanne, Kenneth Straub, Henry Rapoport et al. · Biochemistry · 1982 · 194 citations · Full text

Rows per page

1–5 of 23